作者: WH Allum , , MT Hallissey , LC Ward , MS Hockey
DOI: 10.1038/BJC.1989.350
关键词: Prospective cohort study 、 Adjuvant therapy 、 Clinical trial 、 Chemotherapy 、 Medicine 、 Radiation therapy 、 Randomized controlled trial 、 Stomach cancer 、 Cancer 、 Surgery
摘要: A prospective, randomised controlled trial of surgery, surgery with adjuvant radiotherapy and chemotherapy (5-fluorouracil, adriamycin mitomycin C) in operable gastric cancer is described. Four hundred thirty-six patients were randomly allocated to one three treatment groups. With 12 months' minimum follow-up, 334 have died, 292 from recurrent cancer. The median survival for all was 15 months. Neither form therapy provides any advantage. Surgery remains the principal Care should be taken standardise surgical treatments must compared within confines controlled, trials.